Page 40 - Multiple Sclerosis Ms News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Findings presented at ECTRIMS 2021 suggest the OTC supplement improves multiple sleep measures

The statement concludes that COVID-19 vaccines are safe for patients with multiple sclerosis and that most MS patients gain the same protection as the general population. But there are exceptions.

New data on COVID vaccination in MS patients has shown a reduced humoral response in patients treated with certain medications -- including ocrelizumab, rituximab, and fingolimod -- but not others.

Patients who developed secondary progressive MS at 20 years had more cortical lesions at baseline than patients with clinically isolated syndrome, relapsing-remitting MS, or primary progressive MS.

A statement by the American Academy of Neurology, American Neurological Association, and Child Neurology Society details ethical concerns about high drug prices -- and what neurologists can do.